A detailed history of Jane Street Group, LLC transactions in Neuroone Medical Technologies Corp stock. As of the latest transaction made, Jane Street Group, LLC holds 39,951 shares of NMTC stock, worth $45,943. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,951
Holding current value
$45,943
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$0.59 - $1.01 $23,571 - $40,350
39,951 New
39,951 $32,000
Q4 2022

Feb 14, 2023

BUY
$0.84 - $2.82 $735 - $2,467
875 Added 4.31%
21,157 $25,000
Q3 2022

Nov 14, 2022

BUY
$0.84 - $2.55 $17,036 - $51,719
20,282 New
20,282 $34,000

Others Institutions Holding NMTC

About NEUROONE MEDICAL TECHNOLOGIES Corp


  • Ticker NMTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,209,200
  • Market Cap $18.6M
  • Description
  • NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...
More about NMTC
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.